Viewing Study NCT03947866


Ignite Creation Date: 2025-12-24 @ 4:12 PM
Ignite Modification Date: 2026-02-21 @ 9:03 AM
Study NCT ID: NCT03947866
Status: UNKNOWN
Last Update Posted: 2023-02-16
First Post: 2019-05-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ezetimibe-Rosuvastatin Evaluation Study
Sponsor: Elpen Pharmaceutical Co. Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypercholesterolemia View
None Hyperlipidemias View
None Combinations of Drugs; Dependence View
Keywords: